Previous close | 26.39 |
Open | 26.59 |
Bid | 25.92 x 500 |
Ask | 25.99 x 300 |
Day's range | 25.87 - 27.40 |
52-week range | 24.60 - 63.57 |
Volume | |
Avg. volume | 1,610,863 |
Market cap | 3.158B |
Beta (5Y monthly) | 1.94 |
PE ratio (TTM) | N/A |
EPS (TTM) | -2.21 |
Earnings date | 01 Aug 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 41.23 |
Review 10x Genomics' (TXG) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that members of its management team will participate in a fireside chat at the BofA Securities 2024 Healthcare Conference on Tuesday, May 14, at 4:20 p.m. Pacific Time.
10x Genomics ( NASDAQ:TXG ) First Quarter 2024 Results Key Financial Results Revenue: US$141.0m (up 5.0% from 1Q 2023...